Billiontoone test reduces need for Rhogam in 40% of Rh-negative pregnancies

Study indicates rh- mothers more likely to have autistic children

https://www.bioworld.com/articles/707612-billiontoone-test-reduces-need-for-rhogam-in-40-of-rh-negative-pregnancies?v=preview

In March, the U.S. FDA reported a major shortage of Rhogam, the anti-D immune globulin most widely used to prevent Rh factor incompatibility in pregnancy. Without treatment, second and subsequent pregnancies can be endangered by antibodies created by the mother. With the shortage, the standard treatment of two shots for all pregnant females with Rh-negative blood can be challenging, but Billiontoone Inc.’s Unity prenatal test can eliminate the need for the immune globulin treatment in 40% of these pregnancies

Are you an Rh negative mother with an Rh positive mother?

What many donors don’t know: Their blood is sold